Head-to-head · Cost-Efficiency Index
PeptidesRx vs TelePeptide
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
PeptidesRx
Cost-first shoppers who want itemized per-vial pricing across every dose tier, for shoppers who read past the '1-week starter' teaser price.
Visit PeptidesRxTelePeptide
Cost-first shoppers who want all-in compounded GLP-1 from $169/mo; LegitScript-certified, 48 states.
Visit TelePeptideThe verdict
PeptidesRx and TelePeptide tie on the Cost-Efficiency Index at 55/100, so neither wins outright on the numbers. For most shoppers we'd start with PeptidesRx (ranked #343, a hair above #348) — Cost-first shoppers who want itemized per-vial pricing across every dose tier, for shoppers who read past the '1-week starter' teaser price. But TelePeptide is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs PeptidesRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | PeptidesRx | TelePeptide |
|---|---|---|
| Cost-Efficiency Index | 55/100 | 55/100 |
| Semaglutide / mo | $321/mo (10 mg dose, compounded) | $199/mo (starting dose, annual plan, compounded oral) |
| Tirzepatide / mo | $576/mo (40 mg dose, compounded) | $219/mo (starting dose, annual plan, compounded oral) |
| Semaglutide / yr (modeled) | $3,852 | $2,388 |
| Tirzepatide / yr (modeled) | $6,912 | $2,628 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #343 | #348 |
PeptidesRx
55/100Where the value is
- Confirmed legitimate clinical telehealth service — licensed provider consultation required before any prescription, with no 'research use only' disclaimer anywhere
- Every dose tier for both drugs is individually priced and published, more granular transparency than most competitors in this batch
- Cancel-anytime, no long-term contract on any SKU
The tradeoffs
- The homepage's 'From $185/mo' and 'From $304/mo' teaser prices are for vials the catalog itself labels a '1-week starter' supply — the genuine 4-week tier costs 69-89% more, and this gap is easy to miss since every tier bills as a monthly auto-renewal regardless of the vial's actual duration
- No compounding pharmacy is individually named, only 'PCAB-accredited US pharmacies'
TelePeptide
55/100Where the value is
- LegitScript-certified (seal ID 49966407); 503A-licensed compounding pharmacies
- All-inclusive from $169/mo annual — physician eval + Rx + medication + shipping, no hidden fees
- Broadest formulation menu: injectable sema/tirz, oral dissolvable tablets, sema+naltrexone, microdose combos
The tradeoffs
- Compounded medications are not FDA-approved; no pharmacy partner named publicly
- Monthly billing costs more — $199/mo (monthly) vs $169/mo (annual) for semaglutide injectable; best rate requires annual prepay
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.